PRO104 DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)
Abstract
Authors
E. Álvarez M.T. Álvarez I. Cuervo-Arango R. Núñez R. Perez-Santamarina J.L. Poveda J.A. Romero M. Queralt Q. Pablo V. Luís M. Tort F.J. Badia